Opendata, web and dolomites

NO-ESKAPE SIGNED

Addressing Antibiotic Resistance: New Strategies for Overcoming the ESKAPE Pathogens

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NO-ESKAPE project word cloud

Explore the words cloud of the NO-ESKAPE project. It provides you a very rough idea of what is the project "NO-ESKAPE" about.

era    post    entirely    worrisome    synthetic    tackle    interfering    discovery    critical    rational    natural    aureus    outlined    positive    bacterial    examined    organic    screening    century    aeruginosa    eskape    alarming    innovation    organisms    action    responsible    health    therapeutic    pursuit    sequestering    pursued    resistance    21st    pathogens    unconventional    suitable    lactamase    bacteria    prepare    gram    faecium    enterobacter    microbial    threat    combating    multidisciplinary    innovative    strategies    escaping    diverse    operate    conventional    combination    drug    identification    precursors    mechanisms    prepared    pneumoniae    cell    antibiotics    survival    head    modes    baumanii    beta    compounds    wealth    clear    enzymes    describes    delivering    biosynthesis    inhibitors    valuable    produces    resistant    collection    antibacterial    almost    semi    world    firmly    validate    poses    grounded    leads    antibiotic    global    wall    chemistry    species    binding    negative    metallo   

Project "NO-ESKAPE" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITEIT UTRECHT 

Organization address
address: HEIDELBERGLAAN 8
city: UTRECHT
postcode: 3584 CS
website: www.uu.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website http://martinlab.nl
 Total cost 2˙000˙000 €
 EC max contribution 2˙000˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2016-COG
 Funding Scheme ERC-COG
 Starting year 2017
 Duration (year-month-day) from 2017-06-01   to  2022-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITEIT UTRECHT NL (UTRECHT) coordinator 2˙000˙000.00

Map

 Project objective

Antibiotic resistance poses an alarming threat to global health. Most worrisome are the so-called “ESKAPE” pathogens (E. faecium, S. aureus, K. pneumoniae, A. baumanii, P. aeruginosa, and Enterobacter species), a collection of organisms capable of escaping the effects of almost all conventional antibiotics. Key to combating drug-resistant bacteria is the identification of new antibacterial targets and the ability to exploit these targets with novel and unconventional antibiotics.

The microbial world produces a wealth of antibacterial compounds that, while not suitable for therapeutic use, operate by diverse and unique modes of action. This proposal describes innovative approaches aimed at the discovery and development of such compounds as leads towards novel antibiotics with entirely new modes of action. Using a multidisciplinary approach, firmly grounded in synthetic organic chemistry, I will prepare and validate new antibiotics that target the ESKAPE pathogens by exploiting mechanisms critical to their survival and/or resistance.

To tackle the Gram-positive ESKAPE pathogens a number of new approaches to interfering with bacterial cell wall biosynthesis will be examined. Specifically, novel (semi)synthetic compounds capable of binding to and sequestering various bacterial cell wall precursors will be prepared and their antibiotic activity assessed. To address the Gram-negative ESKAPE pathogens, inhibitors of the metallo-beta-lactamase enzymes responsible for much of their antibiotic resistance will be pursued. These inhibitors will be achieved via a combination of rational design strategies and innovative natural product screening approaches.

The 21st century threat of a post-antibiotic era makes clear the need for innovation in antibacterial drug discovery. The strategies outlined in this proposal address this threat head-on with the aim of delivering valuable lead compounds in pursuit of novel antibiotics.

 Publications

year authors and title journal last update
List of publications.
2018 Kamaleddin H. M. E. Tehrani, Nathaniel I. Martin
β-lactam/β-lactamase inhibitor combinations: an update
published pages: 1439-1456, ISSN: 2040-2503, DOI: 10.1039/c8md00342d
MedChemComm 9/9 2019-12-16

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NO-ESKAPE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NO-ESKAPE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

DISINTEGRATION (2019)

The Mass Politics of Disintegration

Read More  

PROGRESS (2019)

The Enemy of the Good: Towards a Theory of Moral Progress

Read More  

NanoPD_P (2020)

High throughput multiplexed trace-analyte screening for diagnostics applications

Read More